游戏里的战斗激情,免费无码毛片一区二区A片小说 ,忍着娇喘人妻被中出中文字幕,中文字幕在线亚洲二区

安科生物  
安徽安科生物工程（集團(tuán)）股份有限公司是經(jīng)安徽省人民政府批準(zhǔn)成立的民營股份制企業(yè)，是國家火炬計(jì)劃重點(diǎn)高新技術(shù)企業(yè)，國家“863”計(jì)劃成果產(chǎn)業(yè)化基地,設(shè)有省級技術(shù)中心和博士后科研工作站。是我國規(guī)模最大、效益最好、技術(shù)儲(chǔ)備最雄厚的生物制藥高科技企業(yè)之一。

集團(tuán)公司核心企業(yè)安科生物一直專注于細(xì)胞工程產(chǎn)品、基因工程產(chǎn)品等生物技術(shù)藥品的研發(fā)和核心技術(shù)能力的構(gòu)建。先后承擔(dān)了國家“863”計(jì)劃、國家科技攻關(guān)、國家重點(diǎn)火炬計(jì)劃及省級科技攻關(guān)項(xiàng)目10余項(xiàng)，自主研發(fā)國家級新藥近10個(gè)。先后榮獲國家科技進(jìn)步三等獎(jiǎng)1次、安徽省科技進(jìn)步一等獎(jiǎng)3次、安徽省科技進(jìn)步二等獎(jiǎng)1次、省政府突出貢獻(xiàn)獎(jiǎng)2次、安徽省重大科技成就獎(jiǎng)1次。

近年來安科生物在基因克隆技術(shù)制藥常用的工具酶，基因克隆技術(shù)制藥常用質(zhì)粒載體和噬菌體載體，基因工程藥物目的基因制取，目的基因與克隆載體的體外重組，重組克隆載體引入受體細(xì)胞，目的重組克隆的篩選、鑒定與分析，目的基因在宿主細(xì)胞中的表達(dá)都形成了自己的比較優(yōu)勢。主導(dǎo)產(chǎn)品重組人干擾素α2b“安達(dá)芬”系列制劑、重組人生長激素“安蘇萌”、抗精子抗體檢測（MAR法）試劑盒“安思寶”均由安科自主研發(fā)，暢銷全國并出口十多個(gè)國家和地區(qū)。其中“安達(dá)芬”是我國第一個(gè)國產(chǎn)化干擾素α2b產(chǎn)品，國家“863”計(jì)劃成果“安思寶”是國際上第一個(gè)商品化的MAR法抗精子抗體檢測試劑。目前有國家科技攻關(guān)項(xiàng)目“PEG栝樓根天花粉蛋白”、一類新藥“重組人白蛋白融合干擾素”、“PEG－重組人生長激素”等多個(gè)項(xiàng)目正在研發(fā)當(dāng)中。

成員企業(yè)安徽安科余良卿藥業(yè)有限公司是安科生物重組“百年中華老字號”中藥企業(yè)“余良卿”而成立的。生產(chǎn)橡膠膏劑、合劑、顆粒劑、硬膠囊劑、酊劑、軟膏劑、膏藥劑等七種劑型三十多個(gè)中藥品種。
成員企業(yè)安徽安科恒益藥業(yè)有限公司是專業(yè)從事藥品制劑生產(chǎn)的企業(yè)，主要?jiǎng)┬陀衅瑒?、膠囊劑、顆粒、糖漿劑、膏滋劑、散劑、口服溶液劑等7個(gè)劑型。主要品種有：頭孢克洛分散片、貝諾酯分散片、阿奇霉素散劑、阿莫西林顆粒、頭孢膠囊、顆粒、頭孢拉定膠囊、氨咖黃敏膠囊等 57個(gè)品種。

目前，安科生物正在積極籌備建設(shè)“安徽生物技術(shù)及新醫(yī)藥創(chuàng)新創(chuàng)業(yè)孵化中心”，這個(gè)中心從資金籌措到管理將完全采用“市場化”模式籌建和運(yùn)作。建成后的孵化中心將為我省生物技術(shù)及新醫(yī)藥研究提供嶄新的公共技術(shù)平臺(tái)，并通過中心的孵化作用培養(yǎng)出一批具有較強(qiáng)自主創(chuàng)新能力的生物技術(shù)和新醫(yī)藥研究和產(chǎn)業(yè)化企業(yè)。

We, Anhui Anke Biotechnology (Group) Co., Ltd., professional and leading in developing, manufacturing and marketing pharmaceuticals and health-care products, have developed quickly and made remarkable success in the field of bio- technology. 

Our parent company is located in China Hefei New and High Technology Development Area. As based on high-efficient Research & Development Center, we, AnkeBio always keep up with international development and have been undertaken with 10 subjects such as "National 863 Projects", National scientific and technological project, National key Torch Program and Scientific and Technological Projects, key scientific and technological specialties of Anhui province and Natural Fund Project and etc. and have developed nearly 10 National Novel Drugs in recent years.

Our dominant products, Recombinant Human Growth Hormone (Ansomone?), Series of Recombinant Human Interferon alpha 2b (Anterferon?), MAR Kit for Anti-sperm Antibody and etc., are all developed independently. These products have more and more significant therapeutically effect on clinical testing and application of many kinds of intractable disease such as chronic hepatitis B, tumor, leukemia, nutritional support burned wound and immunopurification sterility and etc.

Our subsidiary companies like Anhui Anke Yuliangqing Pharmaceutical Co., Ltd., Anhui Anke Hengyi Pharmaceutical Co., Ltd. and Anhui Anke Xinxin Pharmaceutical Co., Ltd have been established from recombination of Anqing Yuliangqing Pharmaceutical Co., Ltd.,Tongling NO.1 Pharmaceutical Company dominated by Anke biotechnology Co.,Ltd. since year 2000.The products are extended from biomedical products into modern Chinese herb medicines and synthetic medicines.

The sales networks of our products have covered more than 30 provinces in China. More than 40 Regional Offices of AnkeBio have built up in the whole China and the international Co-operation has developed quickly.

The mission of AnkeBio is discovering, developing, manufacturing and marketing health-care products with Higher Quality as well as Best Services to improving life quality of human..